MLKL and Alzheimer disease: In a recently published study, the expression of RIPK1, RIPK3, and MLKL, at both mRNA and protein levels, was restricted to the granulovacuolar degenerative lesions in degenerating neurons of AD and in preclinical stages of AD pathology [81].